Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)
Abstract Background In critically ill patients, tigecycline (TGC) remains an important therapeutic option due to its efficacy against multiresistant Gram-positive and Gram-negative bacteria. TGC is metabolized and eliminated predominantly by the liver. Critical illness-induced liver failure may have...
Main Authors: | Rawan Alraish, Sebastian G. Wicha, Otto R. Frey, Anka C. Roehr, Johann Pratschke, Martin Stockmann, Tilo Wuensch, Magnus Kaffarnik |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-08-01
|
Series: | Annals of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13613-020-00707-2 |
Similar Items
-
The LiMAx Test as Selection Criteria in Minimally Invasive Liver Surgery
by: Mirhasan Rahimli, et al.
Published: (2022-05-01) -
Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study.
by: Magnus F Kaffarnik, et al.
Published: (2017-01-01) -
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis
by: Catherine Leyh, et al.
Published: (2022-09-01) -
Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients
by: Lisa F. Amann, et al.
Published: (2022-04-01) -
Perioperative LiMAx Test Analysis: Impact of Portal Vein Embolisation, Chemotherapy and Major Liver Resection
by: Felix Rühlmann, et al.
Published: (2024-01-01)